Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Pharmacology

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1111/bph.13562PMID 27448286PMCID PMC5275771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis

  2016cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015influential reference
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Transporters

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Overview

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors

  2015cited by this paper
• Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells.

  2015cited by this paper
• Current applications of adipose-derived stem cells and their future perspectives.

  2014cited by this paper
• Apoptotic cell: linkage of inflammation and wound healing

  2014cited by this paper
• Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension

  2014influential reference
• The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.

  2014cited by this paper
• The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice

  2014influential reference
• Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.

  2014cited by this paper
• Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats.

  2014cited by this paper
• Microvesicles as mediators of tissue regeneration.

  2014influential reference
• Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis

  2014cited by this paper
• Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells

  2014cited by this paper
• Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension

  2014cited by this paper
• Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension.

  2014cited by this paper
• Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models.

  2013cited by this paper
• Endothelial-Like Progenitor Cells Engineered to Produce Prostacyclin Rescue Monocrotaline-Induced Pulmonary Arterial Hypertension and Provide Right Ventricle Benefits

  2013cited by this paper
• Immunomodulatory Effects of Adipose-Derived Stem Cells: Fact or Fiction?

  2013cited by this paper
• Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells

  2013cited by this paper
• Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats.

  2012cited by this paper
• The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations

  2012cited by this paper
• Inflammation in pulmonary arterial hypertension.

  2012cited by this paper
• Stem cells and pulmonary fibrosis: cause or cure?

  2012cited by this paper
• Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

  2012cited by this paper
• Analysis of in vitro secretion profiles from adipose-derived cell populations

  2012cited by this paper
• Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

  2012cited by this paper
• High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4

  2012cited by this paper
• New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis.

  2012cited by this paper
• Regenerative pulmonary medicine: potential and promise, pitfalls and challenges

  2012cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Treatment of pulmonary arterial hypertension with targeted therapies

  2011cited by this paper
• Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy.

  2011cited by this paper
• Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells

  2011cited by this paper
• A cell‐free extract from human adipose stem cells protects mice against epilepsy

  2011cited by this paper
• Mechanisms of disease: pulmonary arterial hypertension

  2011cited by this paper
• Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration

  2011cited by this paper
• Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine.

  2010influential reference
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

  2010cited by this paper
• Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats

  2010cited by this paper
• Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

  2010cited by this paper
• Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

  2009cited by this paper
• Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension

  2009cited by this paper
• Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

  2009cited by this paper
• Inhibition of inducible nitric oxide synthase in respiratory diseases.

  2009cited by this paper
• Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

  2008cited by this paper
• Interleukin 4 inhibits TGF-β-induced-Foxp3+T cells and generates, in combination with TGF-β, Foxp3− effector T cells that produce interleukins 9 and 10

  2008cited by this paper
• Stem cell migration: a quintessential stepping stone to successful therapy.

  2007cited by this paper
• Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats.

  2007cited by this paper
• Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis.

  2007cited by this paper
• Implantation of Mesenchymal Stem Cells Overexpressing Endothelial Nitric Oxide Synthase Improves Right Ventricular Impairments Caused by Pulmonary Hypertension

  2006cited by this paper
• Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth.

  2006cited by this paper
• Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease

  2005cited by this paper
• CCL23/myeloid progenitor inhibitory factor-1 inhibits production and release of polymorphonuclear leukocytes and monocytes from the bone marrow.

  2005cited by this paper
• Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

  2004cited by this paper
• SERIES 0 ADVANCES IN PATHOBIOLOGY , DIAGNOSIS , AND TREATMENT OF PULMONARY HYPERTENSION 0

  2003cited by this paper
• Inhibition of Matrix Metalloproteinases by Lung TIMP-1 Gene Transfer Limits Monocrotaline-Induced Pulmonary Vascular Remodeling in Rats

  2003cited by this paper
• Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).

  2002cited by this paper
• Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1.

  1995cited by this paper
• Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

  1988cited by this paper
• Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography.

  1987cited by this paper

• Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients

  2024cites this paper
• Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications

  2024cites this paper
• Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats

  2023cites this paper
• Long-term follow-up and exploration of the mechanism of stromal vascular fraction gel in chronic wounds

  2023cites this paper
• Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells

  2023cites this paper
• Mesenchymal stromal cell therapy for chronic lung diseases: experimental and clinical evidence

  2023cites this paper
• Therapeutic effect of adipose-derived mesenchymal stem cells (AD-MSCs) compared to pirfenidone on corticosteroid resistance in a mouse model of acute exacerbation of Idiopathic pulmonary fibrosis.

  2022cites this paper
• Mesenchyme Stem Cell-Derived Conditioned Medium as a Potential Therapeutic Tool in Idiopathic Pulmonary Fibrosis

  2022cites this paper
• Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells

  2022cites this paper
• Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices

  2021cites this paper
• Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints

  2021cites this paper
• Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a

  2021cites this paper
• Cellular Therapy for the Treatment of Paediatric Respiratory Disease

  2021cites this paper
• Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application

  2021influential citation
• Anti-fibrotic effect of adipose-derived mesenchymal stem cell conditioned medium in muscle fibrosis.

  2021cites this paper
• Secretome of Multipotent Mesenchymal Stromal Cells as a Promising Treatment and for Rehabilitation of Patients with the Novel Coronaviral Infection

  2021cites this paper
• Adipose Tissue Fibrosis: Mechanisms, Models, and Importance

  2020cites this paper
• Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis

  2020cites this paper
• Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra

  2020cites this paper
• Therapeutic applications of adipose cell-free derivatives: a review

  2020cites this paper
• Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.

  2020cites this paper
• Effects of mesenchymal stromal cell-conditioned media on measures of lung structure and function: a systematic review and meta-analysis of preclinical studies

  2020cites this paper
• Murine models of cardiovascular damage in lung diseases

  2020cites this paper
• Expresión exógena de telomerasa humana (hTERT) en células madre mesenquimales derivadas de tejido adiposo humano (A-MSC) como una estrategia para la obtención de líneas celulares

  2020cites this paper
• Mesenchymal Stromal Cells Derived Conditioned Medium in Pulmonary Fibrosis: A Systematic Review and Meta-analysis.

  2020cites this paper
• Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: a systematic review and meta-analysis.

  2019cites this paper
• Conditioned Medium of Mesenchymal Stromal Cells: A New Class of Therapeutics

  2019cites this paper
• Function of Adipose-Derived Mesenchymal Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension through miR-191 via Regulation of BMPR2

  2019cites this paper
• Highlights from the ERS International Congress 2018: Assembly 13 – Pulmonary Vascular Diseases

  2019cites this paper
• Role of bone marrow mesenchymal stem cells in the development of PQ‑induced pulmonary fibrosis.

  2019cites this paper
• Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review

  2019cites this paper
• Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies

  2019cites this paper
• AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.

  2019cites this paper
• microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model

  2019cites this paper
• rBMSC/Cav-1F92A Mediates Oxidative Stress in PAH Rat by Regulating SelW/14-3-3η and CA1/Kininogen Signal Transduction

  2019influential citation
• rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling

  2018cites this paper
• Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching

  2018cites this paper
• The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

  2018cites this paper
• Clinical assessment after human adipose stem cell transplantation into dogs

  2018cites this paper
• Comparative study of the effects of mesenchymal stem cells with different delivery methods in an experimental model of lung fibrosis

  2018cites this paper
• Systemic delivery of mesenchymal stem cells condition media in repeated doses acts as magic bullets in restoring IFN‐&ggr;/IL‐4 balance in asthmatic rats

  2018cites this paper
• Эффекты ингаляционного и внутривенного введения аллогенных мезенхимальных стромальных клеток костного мозга в блеомицин-индуцированной модели легочного фиброза у кроликов

  2018cites this paper
• Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells Reverse Insulin Resistance in Cellular Models

  2017cites this paper
• Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia

  2017cites this paper
• Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension

  2017cites this paper
• Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis

  2016cites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• Stem cell therapy in pulmonary arterial hypertension: current practice and future opportunities

  year unknowncites this paper